Advocacy intelligence hub — real-time data for patient organizations
ConSynance Therapeutics — PHASE2
Bright Minds Biosciences Pty Ltd — PHASE2
Soleno Therapeutics, Inc.
Harmony Biosciences Management, Inc. — PHASE3
University Hospital, Toulouse — NA
University Hospital, Toulouse
treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS)
Rhythm Pharmaceuticals, Inc. — PHASE2
Harmony Biosciences Management, Inc. — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
VYKAT XR
AstraZeneca
Patient Assistance Programs1
Norditropin
Novo Nordisk
Vykat Xr
(DIAZOXIDE CHOLINE)Orphan drugSoleno Therapeutics, Inc.
12.1 Mechanism of Action The exact mechanism of action of diazoxide choline in the treatment of hyperphagia in patients 4 years of age and older with ...
Norditropin
(SOMATROPIN)Orphan drugstandardNovo Nordisk
Recombinant Human Growth Hormone [EPC]
12.1 Mechanism of Action Somatropin binds to dimeric GH receptors located within the cell membranes of target tissue cells. This interaction results i...
Wendy J Dahl, PhD, LMFT
University of Florida
📍 UPTON, MA
Marcelo Serra, PhD
HIBA
📍 Buenos Aires, Buenos Aires
Graziano Grugni
Istituto Auxologico Italiano
Anish Bhatnagar, MD
Soleno Therapeutics
📍 NEWARK, NJ
Kim Krogsgaard
Saniona
Jean-Pierre Chanoine
University of British Columbia